Calcium & Bone MetabolismMay 12, 20266 min read

Everything You Need to Know About Vitamin D metabolism for Step 1

Deep dive: definition, pathophysiology, clinical presentation, diagnosis, treatment, HY associations for Vitamin D metabolism. Include First Aid cross-references.

Vitamin D questions on Step 1 love to look “simple” (sunlight → strong bones) and then test you on the one enzyme, organ, or regulator that breaks the chain. If you can trace vitamin D from skin → liver → kidney → intestine/bone and map what PTH, phosphate, FGF23, and kidney disease do to that pathway, you’ll crush most calcium/bone metabolism stems.


Big Picture: What Vitamin D Does (and Why Step 1 Cares)

Vitamin D (calcitriol, 1,25(OH)2D1,25(OH)_2D) is a steroid hormone that primarily:

  • Increases intestinal absorption of calcium and phosphate
  • Promotes bone mineralization when Ca/Phos supply is adequate
  • Can increase bone resorption (via RANKL) in certain contexts to maintain serum calcium

On exams, vitamin D is often tested in the context of:

  • Rickets/osteomalacia
  • CKD (renal osteodystrophy)
  • Hypo/hyperparathyroidism
  • Malabsorption
  • Granulomatous disease → hypercalcemia

Vitamin D Metabolism: The High-Yield Pathway

Stepwise conversion (know the organs + enzymes)

StepSubstrate → ProductWhereEnzymeRegulation (HY)
17-dehydrocholesterol → Cholecalciferol (D3)SkinUVB↓ with sunscreen, darker skin, low sun exposure
2D3 → 25-hydroxyvitamin D (calcidiol)Liver25-hydroxylaseMostly substrate-driven; best measure of body stores
325(OH)D → 1,25-dihydroxyvitamin D (calcitriol)Kidney (proximal tubule)1α-hydroxylase↑ by PTH, ↓ by phosphate, ↓ by FGF23

Two lab values that Step 1 loves to trick you with

  • 25(OH)D (calcidiol) = storage form and best test for vitamin D deficiency
  • 1,25(OH)2_2D (calcitriol) = active form and can be normal or even high in deficiency (because PTH upregulates 1α-hydroxylase)

Regulation: Who Turns Calcitriol Up or Down?

Parathyroid hormone (PTH): the “kidney activator”

Low calcium → ↑ PTH → kidney:

  • ↑ 1α-hydroxylase → ↑ calcitriol
  • ↑ Ca reabsorption (DCT)
  • ↓ phosphate reabsorption (PCT) → phosphaturia
  • ↑ bone resorption (via osteoblast RANKL → osteoclast activation)

Net: raises serum calcium; lowers serum phosphate.

Phosphate & FGF23: the “calcitriol brakes”

  • High phosphate stimulates FGF23 (made by osteocytes)
  • FGF23:
    • ↓ 1α-hydroxylase → ↓ calcitriol
    • ↓ phosphate reabsorption in PCT (phosphaturia)

Classic teaching: FGF23 is the body’s “anti-phosphate” hormone and reduces active vitamin D.


Mechanism of Action: How Vitamin D Works at Target Tissues

Intestine (highest yield)

Calcitriol increases:

  • Calcium absorption (via ↑ TRPV6 channels, ↑ calbindin)
  • Phosphate absorption

Bone

Vitamin D:

  • Supports mineralization by providing Ca/Phos availability
  • In conjunction with PTH, can promote resorption (upregulates RANKL via osteoblasts)

Kidney

Calcitriol modestly:

  • Increases Ca/Phos reabsorption, but its major “exam effect” is through the gut.

Deficiency: Pathophysiology You’ll Actually See in Questions

Common causes

  • Low sunlight exposure (institutionalized, high latitude)
  • Darker skin (melanin blocks UVB)
  • Malabsorption (celiac, Crohn, pancreatic insufficiency, bariatric surgery)
  • Liver disease (↓ 25-hydroxylation)
  • CKD (↓ 1α-hydroxylation → low calcitriol)
  • Medications: enzyme inducers like phenytoin, phenobarbital (increase vitamin D catabolism)

What deficiency does to labs (pattern recognition)

Low vitamin D → ↓ intestinal Ca/Phos absorption → low calcium (or low-normal) → secondary hyperparathyroidism → phosphate wasting.

Typical deficiency labs:

  • ↓ 25(OH)D
  • ↓ Ca (may be low-normal early)
  • ↓ phosphate (because PTH wastes phosphate)
  • ↑ PTH
  • ↑ alkaline phosphatase (high bone turnover/osteoblast activity)
💡

HY nuance: In early deficiency, calcium may be normal due to compensatory PTH—so the giveaway becomes low phosphate + high PTH + high ALP + low 25(OH)D.


Clinical Presentations (Step-Style)

Rickets (kids)

Think: failure of mineralization at growth plates.

  • Bone deformities: bowed legs (genu varum), knock-knees
  • Rachitic rosary (enlarged costochondral junctions)
  • Craniotabes, delayed closure of fontanelle
  • Delayed growth, delayed tooth eruption

Osteomalacia (adults)

Think: poorly mineralized osteoid.

  • Diffuse bone pain, tenderness
  • Proximal muscle weakness
  • ↑ fracture risk (especially insufficiency fractures)

Diagnosis: What to Order and How to Interpret It

Best initial test for vitamin D status

  • Serum 25(OH)D

Helpful add-ons (often tested together)

  • Calcium, phosphate, PTH, alkaline phosphatase
  • Consider celiac testing or malabsorption workup if persistent

Imaging clues (less common but very Step 1)

  • Rickets: metaphyseal cupping/fraying on X-ray
  • Osteomalacia: Looser zones/pseudofractures

Treatment (and Exam-Relevant “Which Form Do I Give?”)

Nutritional deficiency (most common)

  • Vitamin D3 (cholecalciferol) supplementation
  • Ensure adequate calcium intake

Malabsorption or severe deficiency

  • Higher-dose vitamin D regimens; sometimes calcidiol/calcitriol depending on context
  • Treat underlying cause (celiac, pancreatic insufficiency, etc.)

CKD: key twist

  • Kidney can’t do 1α-hydroxylation → low calcitriol even if 25(OH)D is okay
  • Treat with active vitamin D:
    • Calcitriol (1,25(OH)2_2D) or analogs (e.g., paricalcitol)
  • Also manage hyperphosphatemia (dietary phosphate restriction, phosphate binders)

Hypervitaminosis D and Hypercalcemia: The “Overdose” Pattern

Excess vitamin D (supplements) → hypercalcemia + hyperphosphatemia because intestinal absorption of both rises.

Findings:

  • Nausea, constipation, polyuria, confusion
  • Nephrolithiasis
  • Shortened QT (hypercalcemia)

Labs:

  • ↑ Ca, ↑ phosphate, ↓ PTH

Management is cause-dependent (stop supplements; IV fluids; consider bisphosphonates/calcitonin if significant hypercalcemia).


High-Yield Associations & Classic Vignettes

1) Chronic kidney disease → low calcitriol → secondary hyperparathyroidism

Mechanism: ↓ 1α-hydroxylase + phosphate retention → ↓ Ca → ↑ PTH
Labs: ↓ Ca, ↑ phosphate, ↑ PTH, ↑ ALP
Buzzwords: “renal osteodystrophy,” bone pain, pruritus, vascular calcifications.

2) Granulomatous disease (sarcoid, TB) → hypercalcemia

Macrophages express 1α-hydroxylase outside kidney → ↑ calcitriol independent of PTH.

Labs: ↑ Ca, ↓ PTH, ↑ 1,25(OH)2_2D
Clue: hypercalcemia in sarcoidosis with hilar adenopathy.

3) Anticonvulsants (phenytoin/phenobarbital) → vitamin D deficiency

Induce CYP450 → ↑ vitamin D breakdown → osteomalacia/rickets risk.

4) Liver disease affects 25-hydroxylation

Leads to low 25(OH)D and downstream effects.


Rapid-Fire Step 1 “If You See X, Think Y”

  • Best indicator of vitamin D stores25(OH)D
  • PTH increases calcitriol → stimulates 1α-hydroxylase
  • FGF23 decreases calcitriol and increases phosphate wasting
  • CKD → can’t activate vitamin D → treat with calcitriol
  • Sarcoidosis/TB → ectopic 1α-hydroxylase → hypercalcemia with low PTH
  • Vitamin D deficiency↑ PTH, ↑ ALP, often ↓ phosphate

First Aid Cross-References (Where This Lives in FA)

Use these as your quick “flip-to” anchors (edition-dependent headings may shift slightly):

  • Endocrine → Calcium homeostasis: PTH vs vitamin D actions (bone, kidney, gut)
  • Renal → Chronic kidney disease: secondary hyperparathyroidism / renal osteodystrophy
  • Musculoskeletal → Bone disorders: rickets, osteomalacia, osteoporosis differentiation
  • Endocrine pharmacology: vitamin D preparations (cholecalciferol, ergocalciferol, calcitriol)

(Exact page numbers vary by edition; search within FA for “1α-hydroxylase,” “FGF23,” “rickets,” and “renal osteodystrophy.”)


Mini Table: Differentiate Bone Conditions Fast

ConditionPrimary problemCalciumPhosphatePTHALP
Vitamin D deficiency (rickets/osteomalacia)Low mineralization (low Vit D)↓ / low-normal
CKD bone disease↓ calcitriol + phosphate retention
Primary hyperparathyroidismExcess PTH
Vitamin D toxicityExcess absorptionvariable